Which sessions are most relevant to our priorities?
Which speakers or companies would be valuable to hear from?
What insight could benefit our team or organisation?
How might the discussions inform our strategy or decision-making?
Make the case to attend
Why the right event matters
At a time of rapid change across markets, technology and geopolitics, access to trusted insight and informed debate is more valuable than ever. With time and budgets under pressure, choosing the right forum matters.
Attending an FT Live event is an investment in sharper thinking, stronger connections and better-informed decisions. If you need approval to attend, the points below may help outline the value.
What you could gain from attending
At Global Pharma and Biotech Summit, delegates typically benefit from:
Two days of curated content and discussion exploring the forces reshaping the pharma and biotech industry
55+ senior speakers and industry leaders
Opportunities to meet and exchange perspectives with a senior, international and decision-focused audience
Direct access to FT journalists and expert moderators
Senior advisers and industry specialists
What your organisation gains
Sending delegates to Global Pharma and Biotech can help your organisation:
Stay informed about key developments affecting the pharma and biotech industry
Hear directly from senior leaders and independent experts
Benchmark priorities against peers and competitors
Identify new ideas, partners or opportunities
Strengthen decision-making with trusted insight
Maximise the value of limited time and professional development budgets
Planning your business case
As you prepare your request, focus on how the event supports your priorities:
Use our downloadable template to quickly draft an email to your manager about attending Global Pharma and Biotech Summit.

What delegates say they gained
Delegates highlight the value of what they learned and could apply to their work, including:
Strategic insight
“The FT event is THE event of the year for me. It provides a truly different perspective and highlights our industry's opportunities as well as the challenges. The mixture of backgrounds, culture and company types of the attendees makes it really insightful. I like the honesty and directness of both the journalists and the speakers/ panellists. ”
High-quality discussions
“This was the most useful conference I've attended for some time. Excellent breadth of topics, interesting mix of speakers from across the pharma landscape, and a good balance between panels and deeper fireside chats.”
Trust opinions & Valuable connections
“Good range of topics. Calibre of keynote interviews Not too much selling! Enough variety for everyone to learn something and make new connections.”
Senior perspectives
“Excellent 2 days. Good venue and high profile speakers with a variety of both today and future topics.”
Join the conversation
About FT Live
FT Live is the events division of the Financial Times.
Building on the FT’s global reputation for authority, integrity and accuracy, FT Live convenes senior leaders, policymakers, investors and experts to examine the trends shaping industries, economies and the world we live in.
From bespoke briefings to award-winning annual summits, FT Live events deliver crucial business intelligence and valuable connections, digitally and in person, regionally and globally.